Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: A factor analytic approach

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 17, Issue 1, 2005, Pages 51-60

  Tractenberg, Rochelle E ^a   Weiner, Myron F ^b   Cummings, Jeffrey L ^b   Patterson, Marian B ^b   Thal, Leon J ^b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR; CLINICAL DEMENTIA RATING; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DATA ANALYSIS; EVALUATION; FACTORIAL ANALYSIS; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; SCORING SYSTEM; STATISTICAL ANALYSIS; SYMPTOM; VALIDATION PROCESS;

EID: 14144256478     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.17.1.51     Document Type: Article

References (40)

1. Finkel SI: Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers. J Clin Psychiatry 2001; 62(suppl 21):3-6
2. Cummings JL, Kaufer D: Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited. Neurology 1996; 47:876-883
3. Sarazin M, Pillon B, Giannakopoulos P, et al: Clinicometabolic dissociation of cognitive functions and social behavior in frontal lobe lesions. Neurology 1998; 51:142-148
4. Stuss DT, Levine B: Adult clinical neuropsychology: lessons from studies of the frontal lobes. Annu Rev Psychol 2002; 53:401-433
5. Lockwood KA, Alexopoulos GS, van Gorp WG: Executive dysfunction in geriatric depression. Am J Psychiatry 2002; 159:1119-1126
6. Mendez MF, Perryman KM: Neuropsychiatric features of frontotemporal dementia: evaluation of consensus criteria and review. J Neuropsychiatry Clin Neurosci 2002; 14:424-429
7. Litvan I: Personality and behavioural changes with frontal-subcortical dysfunction, in Frontal-Subcortical Circuits in Psychiatric and Neurological Disorders. Edited by Lichter DG, Cummings JL. New York, Guilford, 2001, pp 151-162
8. Tekin S, Mega MS, Masterman DM, et al: Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann Neurol 2001; 49:355-361
9. Royall DR, Lauterbach EC, Cummings JL, et al: Executive control function: a review of its promise and challenges for clinical research: a report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 2002; 14:377-405
10. Elliot R: Executive functions and their disorders. Br Med Bull 2003; 65:49-59
11. Royall DR: Executive cognitive impairment: a novel perspective on dementia. Neuroepidemiology 2000; 19:293-299
12. Royall DR, Polk M: Dementias that present with and without posterior cortical features: an important clinical distinction. J Am Geriatr Soc 1998; 46:98-105
13. Cullum CM, Saine K, Davis-Chan L, et al: A performance-based instrument to assess functional capacity in dementia: the Texas Functional Living Scale. Neuropsychiatr Neuropsychol Behav Neurol 2001; 14:103-108
14. Tractenberg RE, Weiner MF, Patterson MB, et al: Emergent psychopathology in AD patients over 12 months associated with functional, not cognitive, changes. J Geriatr Psychiatry Neurol 2002; 15:110-117
15. Afifi AA, Clark V: Computer-Aided Multivariate Analysis, 3rd ed. Boca Raton, Fla, Chapman & Hall, 1997
16. Cudeck R: Exploratory factor analysis, in Handbook of Applied Multivariate Statistics and Mathematical Modeling. Edited by Tinsley HEA, Brown SD. San Diego, Academic Press, 2000, pp 266-296
17. Ferris SH, Mackell JA, Mohs R, Schneider LS, Galasko D, Whitehouse PJ, Schmitt FA, Sano M, Thomas RG, Ernesto C, Grundman M, Schafer K, Thal LJ: A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results: the Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997; 11(suppl 2):S1-S12
18. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
19. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
20. Lezak MD: Neuropsychological Assessment, 3rd ed. New York, Oxford University Press, 1995
21. Hughes CP, Berg L, Danziger WL, et al: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140:566-572
22. Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43:2412-2414
23. Galasko D, Bennett D, Sano M, et al: An inventory to assess activities of daily living for clinical trials in Alzheimer's disease: The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997; 11(suppl 2):S33-S39
24. Tariot PN, Mack JL, Patterson MB, et al: Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease: The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry 1995; 152:1349-1357
25. Mack JL, Patterson MB: Manual: CERAD Behavior Rating Scale for Dementia, 2nd ed. Durham, NC, Consortium to Establish a Registry for Alzheimer's Disease, 1996
26. Patterson MB, Mack JL, Mackell JA, et al: A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia: the Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997; 11(suppl 2):S40-S44
27. Mack JL, Patterson MB, Tariot PN: The Behavior Rating Scale for Dementia (BRSD): development of test scales and presentation of data for 555 individuals with Alzheimer's disease. J Geriatr Psychiatry Neurol 1999; 12:211-223
28. Tractenberg RE, Jin S, Patterson M, et al: Qualifying change: a method for defining clinically meaningful outcomes of change score computation. J Am Geriatr Soc 2000; 48:1478-1482
29. Tractenberg RE, Gamst A, Thomas RG, et al: Investigating emergent symptomatology as an outcome measure in a behavioral study of Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2002; 14:303-310
30. SAS for Windows, version 8.1. Cary, NC, SAS Institute, 2001
31. Comrey AL, Lee HB: A First Course in Factor Analysis, 2nd ed. Hillsdale, NJ, Lawrence Erlbaum Associates, 1992
32. Cohen L, Holliday M: Practical Statistics for Students: An Introductory Text. London, Paul Chapman Publishing, 1996
33. Stevens J: Applied Multivariate Statistics for the Social Sciences, 3rd ed. Mahwah, NJ, Lawrence Erlbaum Associates, 1996
34. Tekin S, Cummings JL: Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002; 53:647-654
35. Devanand DP, Brockington CD, Moody BJ, et al: Behavioral syndromes in Alzheimer's disease. Int Psychogeriatr 1992; 4(suppl 2):161-184
36. Marin DB, Green CR, Schmeidler J, et al: Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms. J Am Geriatr Soc 1997; 45:1331-1338
37. McCarty HJ, Roth DL, Goode KT, et al: Longitudinal course of behavioral problems during Alzheimer's disease. J Gerontol A Biol Sci Med Sci 2000; 55:M200-M206
38. Cummings JL: Cholinesterase inhibitors: a new class of psychotropic compounds. Am J Psychiatry 2000; 157:4-15
39. Kaufer DI, Cummings JL, Christine D: Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study. J Geriatr Psychiatry Neurol 1996; 9:1-6
40. Weiner MF, Martin-Cook K, Foster BM, et al: Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients. J Clin Psychiatry 2000; 61:487-492